HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duda, P. W. Articles by Hafler, D. A. Search for Related Content PubMed PubMed Citation Articles by Duda, P. W. Articles by Hafler, D. A.

Human and Murine CD4 T Cell Reactivity to a Complex Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate¹

Laboratory of Molecular Immunology, Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115

The capacity of glatiramer acetate (GA), a random copolymer of alanine, lysine, glutamic acid, and tyrosine to stimulate primary in vitro human and murine T cell proliferation was examined. PBMCs isolated from healthy humans and relapsing remitting multiple sclerosis patients and spleen cells from inbred strains of mice, expressing different H-2 haplotypes, were used as sources of non-GA-primed lymphocytes. GA functioned as a universal Ag, inducing dose-dependent proliferation of all non-GA-primed human and murine T cell populations tested. Moreover, GA stimulated PBMCs derived ex vivo from human cord blood, strongly suggesting that GA can activate both naive and memory T cells. The human T cell proliferative responses to GA were HLA class II DR-restricted by virtue of the ability of anti-class II Ab to inhibit T cell proliferation, and the demonstration that individual GA specific human T cell clones were HLA class II DR-restricted by either restriction element but not both. Furthermore, GA-reactive T cells secreted Th0 cytokines and expressed a diverse repertoire of TCR. Limiting dilution analysis indicated that the T cell precursor frequency among the healthy human adults tested ranged from 1:5,000 to 1:125,000. Given that all of the T cell populations tested were isolated from non-GA-primed donors, it appears that virtually all humans and murine strains contain significant numbers of T cell populations cross-reactive with GA. These findings may explain the recent clinical finding that daily s.c. administration of GA ameliorates the progression of multiple sclerosis.

This article has been cited by other articles:

				F. Mastronardi, H. Tsui, S. Winer, D. Wood, T. Selvanantham, C. Galligan, E. Fish, H-M. Dosch, and M. Moscarello Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases Multiple Sclerosis, June 1, 2007; 13(5): 596 - 609. [Abstract] [PDF]

				C. Baecher-Allan, V. Viglietta, and D. A. Hafler Inhibition of Human CD4+CD25+high Regulatory T Cell Function J. Immunol., December 1, 2002; 169(11): 6210 - 6217. [Abstract] [Full Text] [PDF]

				T. Ziemssen, T. Kumpfel, W. E. F. Klinkert, O. Neuhaus, and R. Hohlfeld Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy Brain, November 1, 2002; 125(11): 2381 - 2391. [Abstract] [Full Text] [PDF]

				R. Maron, A. J. Slavin, E. Hoffmann, Y. Komagata, and H. L. Weiner Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines Int. Immunol., February 1, 2002; 14(2): 131 - 138. [Abstract] [Full Text] [PDF]